A comprehensive assessment of statin discontinuation among patients who concurrently initiate statins and CYP3A4-inhibitor drugs; a multistate transition model.
Macarius M DonneyongYuxi ZhuPengyue ZhangYiting LiKatherine M HunoldChienWei ChiangKathleen UnroeJeffrey M CaterinoLang LiPublished in: British journal of clinical pharmacology (2022)
We did not observe any meaningful clinical differences in the probability of premature statin discontinuation between statin users exposed to statin DDIs and those unexposed.